Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2001The Journal of Infectious Diseases

Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

RHRobert C. HolmanPrague University of Economics and BusinessCPChristopher D. PaddockCenters for Disease Control and PreventionACAaron T. CurnsWisconsin Department of Health Services

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Holman et al. (2001) studied this question.

synapsesocial.com/papers/6a73366b2ac1135ea9c8f68ehttps://doi.org/10.1086/324372
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rocky Mountain Spotted Fever: Clinical, Laboratory, and Epidemiological Features of 262 Cases1984 · 339 citations
  2. 2Fatal Rocky Mountain spotted fever1978 · 11 citations
  3. 3Therapeutic Delay and Mortality in Cases of Rocky Mountain Spotted Fever1995 · 192 citations
  4. 4Clinical and Epidemiologic Features of Rocky Mountain Spotted Fever in Mississippi, 1933–19731975 · 21 citations
  5. 5Tick-Borne Diseases — A Growing Risk1995 · 31 citations